{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:32:00Z","timestamp":1773660720631,"version":"3.50.1"},"reference-count":76,"publisher":"Informa UK Limited","issue":"25","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.2217\/fon-2021-0084","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T10:06:11Z","timestamp":1626948371000},"page":"3383-3396","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":25,"title":["Current and Potential Biomarkers in Gastric Cancer: a Critical Review of the Literature"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9640-4573","authenticated-orcid":false,"given":"Ramon Andrade","family":"de Mello","sequence":"first","affiliation":[{"name":"Algarve Biomedical Centre, Faculty of Medicine &amp; Biomedical Sciences, University of Algarve (FMCB UALG),\rFaro\r8005-139, Portugal"},{"name":"Division of Medical Oncology, Escola Paulista de Medicina,Federal University of S\u00e3o Paulo (UNIFESP),\rS\u00e3o Paulo\r04037-004, Brazil"},{"name":"Precision Oncology &amp; Health Economics Group (ONCOPRECH),Post-Graduation Program in Medicine, Nine of July University (UNINOVE),\rS\u00e3o Paulo\r01525-000, Brazil"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-5409","authenticated-orcid":false,"given":"Giovanna Araujo","family":"Amaral","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Escola Paulista de Medicina,Federal University of S\u00e3o Paulo (UNIFESP),\rS\u00e3o Paulo\r04037-004, Brazil"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-9571","authenticated-orcid":false,"given":"Nath\u00e1lia Mois\u00e9s","family":"Neves","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Escola Paulista de Medicina,Federal University of S\u00e3o Paulo (UNIFESP),\rS\u00e3o Paulo\r04037-004, Brazil"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5217-9837","authenticated-orcid":false,"given":"Estela Gudin","family":"Lippo","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Santo Amaro University,\rS\u00e3o Paulo\r01525-000, Brazil"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6040-8214","authenticated-orcid":false,"given":"Fernanda","family":"Parini","sequence":"additional","affiliation":[{"name":"Precision Oncology &amp; Health Economics Group (ONCOPRECH),Post-Graduation Program in Medicine, Nine of July University (UNINOVE),\rS\u00e3o Paulo\r01525-000, Brazil"}]},{"given":"Song","family":"Xu","sequence":"additional","affiliation":[{"name":"Tianjin Medical University General Hospital,\rTianjin, China"}]},{"given":"Maria","family":"Tolia","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy,School of Medicine, University of Crete,\rHeraklion\r715 00, Greece"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8756-9659","authenticated-orcid":false,"given":"Nikolaos","family":"Charalampakis","sequence":"additional","affiliation":[{"name":"Oncology Clinic, H. Dunant Hospital,\r107 Mesogeion Av, Athens115 26, Greece"}]},{"given":"Hakaru","family":"Tadokoro","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Escola Paulista de Medicina,Federal University of S\u00e3o Paulo (UNIFESP),\rS\u00e3o Paulo\r04037-004, Brazil"}]},{"given":"Pedro","family":"Castelo-Branco","sequence":"additional","affiliation":[{"name":"Algarve Biomedical Centre, Faculty of Medicine &amp; Biomedical Sciences, University of Algarve (FMCB UALG),\rFaro\r8005-139, Portugal"}]},{"given":"Jinhui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of General Surgery &amp; Laparoscopic Center,The Second Affiliated Hospital Zhejiang University School of Medicine,\r88 Jiefang Road, Hangzhou310009, China"}]}],"member":"301","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13480"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.143"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i16.4483"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-1057"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3961\/jpmph.15.068"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2011.07.004"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i3.354"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60919-2"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.785865"},{"key":"e_1_3_4_13_1","first-page":"630","volume-title":"In Thompson & Thompson Genetics in Medicine.","author":"Nussbaum RL","year":"2001","unstructured":"Nussbaum RL , McInnesRR, WillardHFet al. Cancer genetics and genomics. In Thompson & Thompson Genetics in Medicine.W.B. Saunders (2001).630\u2013719"},{"issue":"5","key":"e_1_3_4_14_1","first-page":"1511","article-title":"Induction\/reversal of drug resistance in gastric cancer by non-coding RNAs","volume":"54","author":"Chen C","year":"2019","unstructured":"Chen C , TangX, LiuY, ZhuJ, LiuJ. Induction\/reversal of drug resistance in gastric cancer by non-coding RNAs. Int. J. Oncol.54(5), 1511\u20131524 (2019).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-008-9169-0"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800051097"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.5230\/jgc.2017.17.e1"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3738-y"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050733"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.166"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007603"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3816"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2007.00519.x"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2011.07.004"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4522"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067195"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.09.006"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.02.085"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0320"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.05.041"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi064"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1159\/000356201"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.802"},{"issue":"1","key":"e_1_3_4_34_1","first-page":"104","article-title":"Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications","volume":"26","author":"Zheng Z","year":"2014","unstructured":"Zheng Z , BuZ, LiuXet al. Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications. Chin. J. Cancer Res.26(1), 104\u2013111 (2014).","journal-title":"Chin. J. Cancer Res."},{"issue":"10","key":"e_1_3_4_35_1","first-page":"5369","article-title":"Programmed death-1 ligand-1 (PDL1) expression is associated with the prognosis of patients with stage II\/III gastric cancer","volume":"35","author":"Tamura T","year":"2015","unstructured":"Tamura T , OhiraM, TanakaHet al. Programmed death-1 ligand-1 (PDL1) expression is associated with the prognosis of patients with stage II\/III gastric cancer. Anticancer Res.35(10), 5369\u20135376 (2015).","journal-title":"Anticancer Res."},{"issue":"5","key":"e_1_3_4_36_1","first-page":"e180013","article-title":"Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial","volume":"4","author":"Charles S Fuchs","year":"2018","unstructured":"Charles S Fuchs , ToshihikoDoi, RaymondW Jang, KeiMuro, TarohSatoh, ManuelaMachado, WeijingSun. Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial. AMA Oncol.4(5), e180013 (2018).","journal-title":"AMA Oncol."},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-007-2113-1"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/mp.56.5.286"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12187"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep11516"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152569"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0544-0"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14871"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01580-13"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0743-3"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4771"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03345-5"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1069-0"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01185-7"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.637"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0733-6"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-014-0363-1"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0607"},{"issue":"5","key":"e_1_3_4_54_1","first-page":"2719","article-title":"Downregulated microRNA-133a in gastric juice as a clinicopathological biomarker for gastric cancer screening","volume":"17","author":"Shao J","year":"2016","unstructured":"Shao J , FangP-H, HeBet al. Downregulated microRNA-133a in gastric juice as a clinicopathological biomarker for gastric cancer screening. Asian Pac. J. Cancer Prev.17(5), 2719\u20132722 (2016).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-012-0497-x"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4548"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/1535370217728460"},{"issue":"1","key":"e_1_3_4_58_1","first-page":"271","article-title":"Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma","volume":"33","author":"Komatsu S","year":"2013","unstructured":"Komatsu S , IchikawaD, TsujiuraMet al. Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res.33(1), 271\u2013276 (2013).","journal-title":"Anticancer Res."},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.895428"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-170351"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S156921"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10740"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0341-x"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.109"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgv106"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.238"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0254"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4868"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1179"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2015.03.003"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21677"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyq111"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-015-0276-9"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605319"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70096-2"},{"issue":"1","key":"e_1_3_4_76_1","first-page":"89","article-title":"Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin","volume":"32","author":"Kim SY","year":"2008","unstructured":"Kim SY , KimHP, KimYJet al. Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin. Int. J. Oncol.32(1), 89\u201395 (2008).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600310"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.2236"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-0084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:42:58Z","timestamp":1719124978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-0084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":76,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.2217\/fon-2021-0084"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-0084","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}